
Novel мощный inverse агонист of the chemokine рецептор CXCR4, preventing CXCL12-mediated chemotaxis and triggering apoptosis in a panel of 18 клетка lines and primary cultures, with superior mobilizing properties in vivo
Novel potent inverse agonist of the chemokine receptor CXCR4, preventing CXCL12-mediated chemotaxis and triggering apoptosis in a panel of 18 cell lines and primary cultures, with superior mobilizing properties in vivo
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.